Expanded Hemodialysis Therapy Market Players:
- B. Braun Melsungen AG
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Asahi Kasei Corporation
- Baxter International, Inc.
- Fresenius Medical Care AG & Co. KGaA
- Nikkiso Co., Ltd.
- Nipro Corporation
- NxStage Medical, Inc.
- Cantel Medical Corp.
- Satellite Healthcare, Inc.
- MEDIVATORS, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of expanded hemodialysis therapy is evaluated at USD 99.26 billion.
The global expanded hemodialysis therapy market size exceeded USD 95.07 billion in 2025 and is set to expand at a CAGR of over 4.9%, surpassing USD 153.39 billion revenue by 2035.
North America is anticipated to command a 35% share by 2035 in the expanded hemodialysis therapy market, supported by escalating healthcare expenditure, higher disposable incomes, and growing demand for advanced product development.
Key players in the market include B. Braun Melsungen AG, Asahi Kasei Corporation, Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., Nipro Corporation, NxStage Medical, Inc., Cantel Medical Corp., Satellite Healthcare, Inc., MEDIVATORS, Inc.
